Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07570511
Point of Care Testing INR in Antiphospholipid SyndromeCentral Hospital, Nancy, FranceNot Yet RecruitingNot Applicable
NCT07570511Not Yet Recruiting
Not Applicable
Point of Care Testing INR in Antiphospholipid SyndromeCentral Hospital, Nancy,...
NCT07571174
A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral SclerosisEli Lilly and CompanyNot Yet RecruitingPhase 1
NCT07571174Not Yet Recruiting
Phase 1
A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclero...Eli Lilly and Company
NCT07571070
High-Intensity Intermittent Training and Sport-Specific Performance in Youth Amateur BoxersFederal University of VicosaCompletedNot Applicable
NCT07571070Completed
Not Applicable
High-Intensity Intermittent Training and Sport-Specific Performance in Youth Ama...Federal University of Vic...
NCT07571408
Intraoperative Application of Cold Atmospheric Plasma to Prevent Postoperative Wound Complications in the Inguinal Region of High-risk Patients With Peripheral Arterial Occlusive Diseaseneoplas med GmbHNot Yet RecruitingNot Applicable
NCT07571408Not Yet Recruiting
Not Applicable
Intraoperative Application of Cold Atmospheric Plasma to Prevent Postoperative W...neoplas med GmbH
NCT07571668
Effects of Robotic Hand Therapy on Hand Function and Dexterity in Cerebral PalsyRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07571668Not Yet Recruiting
Not Applicable
Effects of Robotic Hand Therapy on Hand Function and Dexterity in Cerebral PalsyRiphah International Univ...
NCT07569887
Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocognitive Disorders in Patients With Unruptured Arteriovenous Malformations Before and After Surgical TreatmentUniversity Hospital, MontpellierNot Yet RecruitingNot Applicable
NCT07569887Not Yet Recruiting
Not Applicable
Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocogni...University Hospital, Mont...
NCT07571928
A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive AzoospermiaMartin Blomberg JensenNot Yet RecruitingPhase 1
NCT07571928Not Yet Recruiting
Phase 1
A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoo...Martin Blomberg Jensen
NCT07571512
In Vitro Microstructural and Mechanical Analysis of Waste Material From Total Knee Arthroplasty for the Study of Innovative Solutions in the Treatment of Joint and Ligament PathologiesStefano ZaffagniniCompleted
NCT07571512Completed
—
In Vitro Microstructural and Mechanical Analysis of Waste Material From Total Kn...Stefano Zaffagnini
NCT07569081
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) SyndromeGlaxoSmithKlineNot Yet RecruitingPhase 2
NCT07569081Not Yet Recruiting
Phase 2
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With V...GlaxoSmithKline
NCT07570368
Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to Enhance Neoadjuvant Chemotherapy Response in Locally Advanced Breast CancerUniversitas AirlanggaNot Yet RecruitingNot Applicable
NCT07570368Not Yet Recruiting
Not Applicable
Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to E...Universitas Airlangga
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07570979
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate CancerNovartis PharmaceuticalsRecruitingPhase 1
NCT07570979Recruiting
Phase 1
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent o...Novartis Pharmaceuticals
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07571057
Effects of an 8-week Jump Squat 15-m Swimming Start SwimmersFederal University of VicosaActive Not RecruitingNot Applicable
NCT07571057Active Not Recruiting
Not Applicable
Effects of an 8-week Jump Squat 15-m Swimming Start SwimmersFederal University of Vic...
NCT07569094
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital of Guangzhou Medical UniversityNot Yet Recruiting
NCT07569094Not Yet Recruiting
—
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital...
NCT07569926
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical RecurrenceBlue Earth DiagnosticsNot Yet RecruitingPhase 4
NCT07569926Not Yet Recruiting
Phase 4
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Managemen...Blue Earth Diagnostics
NCT07569341
Validation of the Classification for Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal MetastasesLinkoeping UniversityCompleted
NCT07569341Completed
—
Validation of the Classification for Resectability and Ablatability Criteria for...Linkoeping University
NCT07571824
A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy SubjectsCorium Innovations, Inc.RecruitingPhase 1
NCT07571824Recruiting
Phase 1
A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy...Corium Innovations, Inc.
NCT07569354
Recovery Among Older Adults Following Mild TBINational Institute on Aging (NIA)Recruiting
Result Breakdown
Not yet recruiting10 (50%)
Recruiting6 (30%)
Completed3 (15%)
Active, not recruiting1 (5%)
not_applicable8 (40%)
Not Specified5 (25%)
Phase 14 (20%)
Phase 22 (10%)
Phase 41 (5%)